NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
Author:
Per Soelberg Sorensen,Svein Ivar Mellgren,Anders Svenningsson,Irina Elovaara,Jette Lautrup Frederiksen,Antonie Giaever Beiske,Kjell-Morten Myhr,Lise Vejby Søgaard,Inge Christoffer Olsen,Magnhild Sandberg-Wollheim
Publication:
The Lancet Neurology
Copyright © 2009 Elsevier Ltd. All rights reserved.